The incidence of severe hypoglycemia in patients with type 2 diabetes was 5% at 26 weeks in patients receiving TOUJEO as part of a multiple daily injection regimen, and 1.0% and 0.9% respectively at 26 weeks in the two studies where patients received TOUJEO as part of a basal-insulin only regimen
Early Phase (Weeks 1 to 3) The first few weeks often produce subtle changes that are easy to overlook
Detailed information on the eligibility criteria can be found in the Methods
The ratiometric readout of RT only responds to GSH (10 mM), but not to glycine (10 mM), cysteine (100 M) or a series of ROS/RNS (100 M)
That growth is driven almost entirely by the success of prescription GLP-1 drugs and the desire of consumers to access similar benefits without injections, prescriptions, or high costs
For a patient with severe dysautonomia or a broken cellular energy metabolism, the physical act of digesting a heavy meal can actually trigger a symptom crash or post-exertional malaise (PEM)